Is ultomirispregnancystudy.com a Scam? Security Check Results - IQVIA

AI Summary

The Ultomiris Pregnancy Registry Study website serves as a clinical research platform focused on enrolling and informing pregnant or breastfeeding women who have been prescribed ULTOMIRIS for autoimmune conditions. The site is professionally designed and targets both patients and healthcare providers in the United States. It provides detailed information about the study, medication, and participation methods, supported by links to official prescribing information and medication guides. The parent company IQVIA is prominently referenced, lending credibility to the site. Technically, the website employs a modern technology stack including jQuery, Bootstrap, Vue.js, and Google Tag Manager, with Sitecore CMS inferred from cookie names. The site is mobile-optimized and includes accessibility features, though some improvements could be made. Security measures include HTTPS enforcement, Google reCAPTCHA integration, and a comprehensive cookie consent mechanism. However, explicit security headers are not detected, and no incident response or security policy pages are present. From a security and compliance perspective, the site demonstrates good privacy compliance with clear privacy and cookie policies and user consent mechanisms. The absence of WHOIS data for the domain is a notable anomaly, reducing trust slightly, but the professional content and association with IQVIA mitigate concerns. No vulnerabilities or exposed sensitive data were detected. Overall, the website is a credible and professionally maintained clinical research registry with moderate to good technical and security posture. Strategic improvements in security headers, incident response transparency, and domain registration clarity would enhance trust and compliance.